The Christie Foundation Trust Annual Report and Accounts 2021-22

The Christie NHS Foundation Trust Annual Report & Accounts 2021-22

Pharmacy

Response to COVID-19 Pharmacy has continued to play a key role in supporting patients and clinicians during the pandemic. Initiatives minimising on site attendance including home-delivery have continued during 2021/22. The department also continues to play a key role in the planning and implementation of the Trust’s COVID-19 vaccination programme. Despite the challenges of the pandemic, teams have continued to develop and innovate. In year developments include: • Establishment of the Christie@Macclesfield pharmacy service. • Pilot Pharmacy led urology out-patient clinic at Christie@Oldham. • Leading the GM Pharmacy Hub collaboration project across NHS hospitals to improve the efficiency of the medication supply chain. • Implementation of a Clinical Trial Courier service, ensuring that patients continue to have access to innovative treatments. • Replacement of aseptic unit isolators. • Approval of plans for the re-provision of TCP facilities to support outpatient and homecare dispensing, including a new robotic dispensing system, improved patient waiting area and a medication counselling private consultation room. • Development and implementation of an extended weekend working arrangement within the pharmacy department in order to deliver a sustainable, high quality safer service for both patients and staff.

The Pharmacy vision is to provide high quality, sustainable, safe and innovative pharmacy services to all Christie patients within a working environment that consistently values, supports and engages staff whatever their professional discipline or experience. The Clinical Pharmacy team supports the delivery of chemotherapy services at the main Christie site and the Christie@ chemotherapy centres across Greater Manchester (GM), as well as providing a comprehensive range of services in both outpatient and inpatient settings. This includes medicines reconciliation and optimisation, support to the day case Systemic Anti-Cancer Therapy (SACT) delivery units and non-medical prescriber support in a variety of outpatient clinics. Within the Clinical Pharmacy service there is a Homecare pharmacy team which provides specialist pharmacy services to the Christie at Home team, Outreach service and liaises with external Homecare providers. The service is also responsible for the provision of the cyclical dispensing scheme. The Aseptic Services Unit (ASU) prepares high quality medication in accordance with Industry regulations. A significant amount of activity is in the preparation of chemotherapy for clinical trials. A leader in ‘first-in-human’ trials, the Clinical Trials team supports over 500 clinical trials a year by ensuring the safe storage, handling, prescribing and administration of clinical trial medicines for oncology and haematology patients. Set up in December 2017, The Christie Pharmacy Ltd (TCP) is a wholly owned subsidiary of the Trust and provides pharmacy dispensing services to outpatients, inpatients and outreach locations, in addition to the procurement of medication. The teams work collaboratively with each other and pharmacy staff are integral members of the multidisciplinary teams across the various services and disease groups.

18